Insider Transactions in Q1 2021 at Cigna Corp (CI)
Insider Transaction List (Q1 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 24
2021
|
John M Murabito EVP & Chief Admin Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,548
+5.2%
|
-
|
|
Feb 24
2021
|
Kristen Lauria EVP Chief Marketing Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,170
+32.01%
|
-
|
|
Feb 24
2021
|
Matthew G Manders Pres, Government and Solutions |
BUY
Grant, award, or other acquisition
|
Direct |
5,219
+10.26%
|
-
|
|
Feb 24
2021
|
Eric P Palmer Officer |
BUY
Grant, award, or other acquisition
|
Direct |
6,034
+15.62%
|
-
|
|
Feb 24
2021
|
Steven B Miller EVP, Chief Clinical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,287
+4.46%
|
-
|
|
Feb 24
2021
|
Michael W Triplett Special Advisor |
BUY
Grant, award, or other acquisition
|
Direct |
2,690
+10.73%
|
-
|
|
Feb 24
2021
|
Jason D Sadler Pres., International Health |
BUY
Grant, award, or other acquisition
|
Direct |
2,555
+8.35%
|
-
|
|
Feb 24
2021
|
Everett Neville EVP, Solutions & Corp Devt. |
BUY
Grant, award, or other acquisition
|
Direct |
2,456
+20.0%
|
-
|
|
Feb 24
2021
|
Hoeltzel Mary T Agoglia SVP Tax & Chief Acct. Officer |
BUY
Grant, award, or other acquisition
|
Direct |
585
+7.89%
|
-
|
|
Feb 11
2021
|
Nicole S Jones Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,950
+2.83%
|
$132,600
$68.38 P/Share
|
|
Feb 10
2021
|
Nicole S Jones Officer |
SELL
Open market or private sale
|
Direct |
9,275
-22.74%
|
$1,966,300
$212.32 P/Share
|
|
Feb 10
2021
|
Nicole S Jones Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
9,275
+10.13%
|
$630,700
$68.38 P/Share
|
|
Feb 08
2021
|
Timothy C Wentworth CEO Evernorth |
SELL
Open market or private sale
|
Indirect |
5,144
-6.27%
|
$1,049,376
$204.86 P/Share
|
|
Feb 04
2021
|
Steven B Miller EVP, Chief Clinical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
622
-2.31%
|
$130,620
$210.53 P/Share
|
|
Feb 04
2021
|
Timothy C Wentworth CEO Evernorth |
SELL
Payment of exercise price or tax liability
|
Direct |
4,554
-9.69%
|
$956,340
$210.53 P/Share
|
|
Jan 22
2021
|
David Cordani Chairman & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
13,772
+19.21%
|
$798,776
$58.73 P/Share
|
|
Jan 21
2021
|
Jason D Sadler Pres., International Health |
SELL
Open market or private sale
|
Direct |
2,000
-7.28%
|
$460,000
$230.04 P/Share
|
|
Jan 21
2021
|
David Cordani Chairman & CEO |
SELL
Open market or private sale
|
Direct |
55,176
-55.54%
|
$12,690,480
$230.0 P/Share
|
|
Jan 21
2021
|
David Cordani Chairman & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
55,176
+35.71%
|
$3,200,208
$58.73 P/Share
|
|
Jan 21
2021
|
Matthew G Manders Pres, Government and Solutions |
SELL
Open market or private sale
|
Direct |
5,596
-12.16%
|
$1,287,080
$230.06 P/Share
|
|
Jan 13
2021
|
David Cordani Chairman & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
13,667
+23.63%
|
$792,686
$58.73 P/Share
|
|
Jan 12
2021
|
David Cordani Chairman & CEO |
SELL
Open market or private sale
|
Direct |
55,280
-64.45%
|
$12,438,000
$225.0 P/Share
|
|
Jan 12
2021
|
David Cordani Chairman & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
55,280
+39.19%
|
$3,206,240
$58.73 P/Share
|
|
Jan 07
2021
|
Steven B Miller EVP, Chief Clinical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
777
+2.81%
|
$124,320
$160.66 P/Share
|
|
Jan 06
2021
|
Steven B Miller EVP, Chief Clinical Officer |
SELL
Open market or private sale
|
Direct |
8,972
-25.58%
|
$1,884,120
$210.0 P/Share
|
|
Jan 06
2021
|
Steven B Miller EVP, Chief Clinical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,972
+20.37%
|
$1,435,520
$160.66 P/Share
|